Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T13:42:03.334Z.
Calculation as of: 2026-10-06T13:42:03.334Z.
Quote observation: 2026-10-06T13:40:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3e31615b66e5acc6c2b7b3f8a521ec69124b31f47383f0f9627e8176a83f275d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$4.75B
EV/Sales Ratio
2.98x
TTM Avg
2.27x
3Y Avg
2.39x
5Y Avg
2.98x
Market Cap
$4.87B
EV/Sales Ratio
2498.44x
TTM Avg
1670.59x
3Y Avg
767.91x
5Y Avg
667.74x
Market Cap
$4.88B
EV/Sales Ratio
16.61x
TTM Avg
10.97x
3Y Avg
7.20x
5Y Avg
8.58x
Market Cap
$4.65B
EV/Sales Ratio
21.87x
TTM Avg
14.60x
3Y Avg
14.88x
5Y Avg
14.88x
Market Cap
$5.10B
EV/Sales Ratio
11.81x
TTM Avg
13.65x
3Y Avg
13.65x
5Y Avg
13.65x
Market Cap
$5.15B
EV/Sales Ratio
N/A
TTM Avg
9.73x
3Y Avg
35.19x
5Y Avg
37.28x
Market Cap
$4.46B
EV/Sales Ratio
3.56x
TTM Avg
3.64x
3Y Avg
2.36x
5Y Avg
2.44x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.81B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.75B | 2.98x | 2.27x | 2.39x | 2.98x |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.87B | 2498.44x | 1670.59x | 767.91x | 667.74x |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.88B | 16.61x | 10.97x | 7.20x | 8.58x |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.65B | 21.87x | 14.60x | 14.88x | 14.88x |
| Erasca, Inc. (ERAS)vs › | $5.06B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $5.10B | 11.81x | 13.65x | 13.65x | 13.65x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.15B | N/A | 9.73x | 35.19x | 37.28x |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.46B | 3.56x | 3.64x | 2.36x | 2.44x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.16B | 3.50x | 3.38x | 3.94x | 3.84x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
